Cambridge, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of transatlantic cancer immunotherapeutics designed to target a novel class of tumor-specific antigens. Epitopea is based in Cambridge, United Kingdom and was founded in 2021. It has raised $44.4 million.
Last price · $/share
—
Implied valuation
—
Total raised
$44.4M
Last round
—
Team — not yet on record
No current team members for Epitopea are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Epitopea with a free account
·The complete investor list: 15 names
·Watch Epitopea: the Monday email on marks, rounds and moves
